Synopsys earns $2.75B in cash behind Ansys amortization

1. Summary

This piece asks whether the cash Synopsys generates behind its Ansys amortization justifies the price, and whether falling backlog is an early warning. Reported profit understates the business: trailing free cash flow was about $2,748M against $802M of operating profit, and the quarter's $545.7M of net income leaned on a $425.4M gain from selling Processor IP ^[1][2][3].

The Thesis scores Synopsys on the four gate tests, and the Valuation shows what five years of growth and margin must deliver to beat today's price. The Financial update separates the one-time gain and amortization from the cash, which has cut debt to $10.04B from $14.34B a year earlier ^[1][3].

The Risks section weighs backlog, which fell to $10.9B from $11.4B, alongside deal debt, restructuring and China exposure ^[1][2]. Our view is hold: a strong gate already priced for it.

2. Thesis

Synopsys owns the design record for advanced chips, from EDA through sign-off, and Ansys adds the physics simulation that superintelligence chips and systems need ^[1].

What invalidates it: Backlog keeps falling from $11.4B while free cash flow stops paying down debt ^[1][2].

3. Valuation

Enterprise value is about $98.78B, our calculation, which is 10.49x trailing revenue, 35.95x free cash flow of about $2,748M and 54.95x owner free cash flow of about $1,798M ^[1].

Five-year view, our calculations. We start from trailing revenue of about $9.42B and an owner free cash flow margin of about 19.09%, meaning free cash flow less stock pay of $950M, our calculation ^[1][2]. Growth rates, margins and exit multiples below are our assumptions, not company guidance.

The base case needs Ansys to grow inside the design flow and owner margin to rise as amortization and integration costs fade, and lands near today's value. Debt paydown adds equity value not shown in the table.

4. Financial update

Reading the third quarter

Revenue for the quarter ended July 31 was $2,477M, up 42% from $1,740M, mostly because Ansys was not in the year-earlier quarter ^[1]. Ansys was 28.7% of revenue, EDA 51.8% and Design IP 19.1% ^[1].

Operating profit was $357.5M ^[1]. That is after $402.4M of acquired intangible amortization, $247.3M in cost of revenue and $155.2M in operating expenses, against $74.9M a year earlier ^[1].

Operating profit before that amortization would have been about $759.9M, our calculation.

Then the other income line jumped to $459.7M ^[1]. On June 1, Synopsys sold Processor IP to GlobalFoundries for $443.3M and "recognized a pre-tax gain on sale of $425.4 million, which was included in other income (expense), net" ^[1].

Net of $44.9M of related costs, the gain was $380.5M ^[1]. Net income was $545.7M ^[1].

Strip out the gain and the quarter looks very different.

The cash behind the amortization

Over the 12 months to July 31, revenue was $9,417M and operating profit $802M, our calculation ^[1][2]. Operating cash flow was $2,938M and capex $191M, for free cash flow of about $2,748M, a 29.18% margin, our calculation ^[1][2].

Stock pay was $950M, which leaves owner free cash flow of about $1,798M ^[1][2].

That cash is going to the deal debt. Total debt was $10.04B at July 31, down from $14.34B a year earlier, with $1,020M now due within a year ^[1][3].

It has held near $10.04B since January ^[4][5]. Cash was $3,606M

What the gate is worth

Synopsys is one of the clearest toll gates in software. Chip designers cannot tape out at a leading foundry without its tools and IP, and Ansys extends that into package, thermal and system simulation ^[1].

R&D was $720M in the quarter, 29.06% of revenue, our calculation, most of it on the core flow rather than on features ^[1]. Its pricing is licenses and subscriptions, not outcomes, but the record and the foundry connection are hard to route around.

A buyer is paying for Ansys to grow inside the flow and for debt paydown to keep turning into equity value.

5. Risks

Backlog is shrinking. Contracted but unsatisfied performance obligations were about $10.9B at July 31, 2026, including $1.9B of non-cancellable FSA commitments, down from about $11.4B, including $2.0B of FSA, at October 31, 2025 ^[1][2]. About 49% of the July backlog, excluding FSA, is expected to turn into revenue over the next 12 months ^[1].

Synopsys sold Optical Solutions and Processor IP during the period, and the 10-Q cites the Optical Solutions sale as lowering license revenue, but it does not say how much of the backlog decline came from the divestitures ^[1]. Without that split, we cannot rule out that the core order book is softening, so backlog is the number to watch at fiscal year end.

Deal debt and maturities. Synopsys funded Ansys with $10.0B of senior notes maturing from April 1, 2027 to April 1, 2055, plus term loans it has since repaid in full ^[1]. Total debt was $10.04B at July 31, 2026, with $1,020M due within a year, mainly the $1.0B of notes due April 1, 2027, and another $1.0B due April 1, 2028 ^[1].

Interest expense was $429.3M over nine months ^[1]. Cash of $3,606M covers the next maturity, but debt has held near $10.04B for three quarters as cash has shifted toward buybacks, and the revolving credit facility carries a maximum leverage covenant

6. Catalysts and conclusion

Fiscal fourth quarter results, for the year ending Oct 31, 2026, will show whether backlog stabilizes and how Ansys grows once the deal laps ^[1].

Stock position: hold. Synopsys is one of the strongest gates in software, and the price already reflects it. We would add on backlog growth or a lower valuation.

What it means for the future of software. Superintelligence needs chips, and chips cannot be built without design software that foundries certify. The gate with the most leverage sits upstream of the hardware itself.